Not applicableStudy completedNCT07315100What this trial is testingNavigated Partial NephrectomyWho this might be right forRenal CancerPartial Nephrectomy The Netherlands Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00719264What this trial is testingSafety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney CancerWho this might be right forCarcinomaAdenocarcinomaRenal Cell+2 more Novartis Pharmaceuticals 365
Not applicableLooking for participantsNCT03747133What this trial is testingSABR for Renal TumorsWho this might be right forRenal Tumor University Health Network, Toronto 90
Not applicableLooking for participantsNCT00582621What this trial is testingAscertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersWho this might be right forLymphomaLeukemiaMultiple Myeloma+2 more Memorial Sloan Kettering Cancer Center 500
Testing effectiveness (Phase 2)Study completedNCT00502307What this trial is testingTivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell AVEO Pharmaceuticals, Inc. 272
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Looking for participantsNCT07072728What this trial is testingPsilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderWho this might be right forAdjustment DisorderAdjustment Disorder With Anxious MoodCancer+8 more Psyence Australia Pty Ltd 87
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Active Not RecruitingNCT05238883What this trial is testingHFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsWho this might be right forGastric CancerRenal Cell CarcinomaMelanoma+6 more HiFiBiO Therapeutics 72
Not applicableStudy completedNCT01971905What this trial is testingPerfusion Scanning's for Kidney TumorsWho this might be right forKidney Cancer Nessn Azawi 56
Testing effectiveness (Phase 2)Ended earlyNCT05714553What this trial is testingNUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursWho this might be right forAdvanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more NuCana plc 19
Testing effectiveness (Phase 2)Looking for participantsNCT07053462What this trial is testingCRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection RiskWho this might be right forEnd-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Testing effectiveness (Phase 2)Ended earlyNCT03185182What this trial is testingDiagnostic Imaging for Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Region Skane 5
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Early research (Phase 1)Study completedNCT00694096What this trial is testingSunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor ResponseWho this might be right forRenal Cell Cancer University of Utah 25
Early research (Phase 1)Looking for participantsNCT05433142What this trial is testingStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Xencor, Inc. 307
Testing effectiveness (Phase 2)WithdrawnNCT03149159What this trial is testingInvestigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent NivolumabWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma Medical University of South Carolina
Not applicableStudy completedNCT00743054What this trial is testingMicroRNA Expression in Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Sun Yat-sen University 50
Not applicableStudy completedNCT00895674What this trial is testingPatient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With NexavarWho this might be right forCarcinoma, Renal CellCarcinoma, Renal Cell (Advanced) Bayer 2,840
Early research (Phase 1)Study completedNCT01334073What this trial is testingStudy of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsWho this might be right forMalignant Advanced Solid TumorsCarcinoma, Renal Cell University Hospital, Bordeaux 19